A phase I study of MEDI6383, an OX40 agonist, in adult patients with select advanced solid tumors Meeting Abstract


Authors: Bauer, T. M.; Chae, Y. K.; Patel, S.; D'Angelo, S. P.; Blumenschein, G. R.; Norton, J.; Pound, C.; Lanasa, M. C.; Curti, B. D.
Abstract Title: A phase I study of MEDI6383, an OX40 agonist, in adult patients with select advanced solid tumors
Meeting Title: 51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036904709
PROVIDER: wos
DOI: 10.1200/jco.2015.33.15_suppl.tps3093
Notes: Meeting Abstract: TPS3093 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sandra Pierina D'Angelo
    252 D'Angelo